Literature DB >> 19893556

Attacking the flu: neutralizing antibodies may lead to 'universal' vaccine.

Grace L Chen1, Kanta Subbarao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19893556      PMCID： PMC3415221          DOI： 10.1038/nm1109-1251

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  13 in total

1.  A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains.

Authors:  Y Okuno; Y Isegawa; F Sasao; S Ueda
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

2.  An epitope shared by the hemagglutinins of H1, H2, H5, and H6 subtypes of influenza A virus.

Authors:  Y A Smirnov; A S Lipatov; A K Gitelman; Y Okuno; R Van Beek; A D Osterhaus; E C Claas
Journal:  Acta Virol       Date:  1999-08       Impact factor: 1.162

3.  Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus.

Authors:  Michelle Roti; Junbao Yang; DeAnna Berger; Laurie Huston; Eddie A James; William W Kwok
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

4.  Mortality associated with influenza and respiratory syncytial virus in the United States.

Authors:  William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Nancy Cox; Larry J Anderson; Keiji Fukuda
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

5.  Influenza-associated hospitalizations in the United States.

Authors:  William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Carolyn B Bridges; Nancy J Cox; Keiji Fukuda
Journal:  JAMA       Date:  2004-09-15       Impact factor: 56.272

6.  Antibody recognition of a highly conserved influenza virus epitope.

Authors:  Damian C Ekiert; Gira Bhabha; Marc-André Elsliger; Robert H E Friesen; Mandy Jongeneelen; Mark Throsby; Jaap Goudsmit; Ian A Wilson
Journal:  Science       Date:  2009-02-26       Impact factor: 47.728

7.  Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion.

Authors:  Rupert J Russell; Philip S Kerry; David J Stevens; David A Steinhauer; Stephen R Martin; Steven J Gamblin; John J Skehel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-12       Impact factor: 11.205

8.  Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals.

Authors:  Laurel Yong-Hwa Lee; Do Lien Anh Ha; Cameron Simmons; Menno D de Jong; Nguyen Van Vinh Chau; Reto Schumacher; Yan Chun Peng; Andrew J McMichael; Jeremy J Farrar; Geoffrey L Smith; Alain R M Townsend; Brigitte A Askonas; Sarah Rowland-Jones; Tao Dong
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

9.  Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.

Authors:  Mark Throsby; Edward van den Brink; Mandy Jongeneelen; Leo L M Poon; Philippe Alard; Lisette Cornelissen; Arjen Bakker; Freek Cox; Els van Deventer; Yi Guan; Jindrich Cinatl; Jan ter Meulen; Ignace Lasters; Rita Carsetti; Malik Peiris; John de Kruif; Jaap Goudsmit
Journal:  PLoS One       Date:  2008-12-16       Impact factor: 3.240

10.  Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza.

Authors:  Cristiana Gioia; Concetta Castilletti; Massimo Tempestilli; Paola Piacentini; Licia Bordi; Roberta Chiappini; Chiara Agrati; Salvatore Squarcione; Giuseppe Ippolito; Vincenzo Puro; Maria R Capobianchi; Fabrizio Poccia
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883
View more
  22 in total

1.  A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection.

Authors:  Brendan M Giles; Corey J Crevar; Donald M Carter; Stephanie J Bissel; Stacey Schultz-Cherry; Clayton A Wiley; Ted M Ross
Journal:  J Infect Dis       Date:  2012-03-23       Impact factor: 5.226

2.  A highly conserved neutralizing epitope on group 2 influenza A viruses.

Authors:  Damian C Ekiert; Robert H E Friesen; Gira Bhabha; Ted Kwaks; Mandy Jongeneelen; Wenli Yu; Carla Ophorst; Freek Cox; Hans J W M Korse; Boerries Brandenburg; Ronald Vogels; Just P J Brakenhoff; Ronald Kompier; Martin H Koldijk; Lisette A H M Cornelissen; Leo L M Poon; Malik Peiris; Wouter Koudstaal; Ian A Wilson; Jaap Goudsmit
Journal:  Science       Date:  2011-07-07       Impact factor: 47.728

Review 3.  Universal fungal vaccines: could there be light at the end of the tunnel?

Authors:  Mawieh Hamad
Journal:  Hum Vaccin Immunother       Date:  2012-08-24       Impact factor: 3.452

4.  Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine.

Authors:  Davide Corti; Amorsolo L Suguitan; Debora Pinna; Chiara Silacci; Blanca M Fernandez-Rodriguez; Fabrizia Vanzetta; Celia Santos; Catherine J Luke; Fernando J Torres-Velez; Nigel J Temperton; Robin A Weiss; Federica Sallusto; Kanta Subbarao; Antonio Lanzavecchia
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

5.  Neutralizing epitopes of influenza virus hemagglutinin: target for the development of a universal vaccine against H5N1 lineages.

Authors:  Mookkan Prabakaran; Fang He; Tao Meng; Selvaraj Madhan; Tan Yunrui; Qiang Jia; Jimmy Kwang
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

6.  CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses.

Authors:  Kristin Scheible; Gang Zhang; Jane Baer; Mitra Azadniv; Kris Lambert; Gloria Pryhuber; John J Treanor; David J Topham
Journal:  Vaccine       Date:  2011-01-04       Impact factor: 3.641

7.  Universal vaccines: shifting to one for many.

Authors:  Antonio Cassone; Rino Rappuoli
Journal:  MBio       Date:  2010-05-18       Impact factor: 7.867

8.  Microsurgeon Hirudo medicinalis as a Natural Bioshuttle for Spontaneous Mass Vaccination against Influenza A Virus.

Authors:  Sara Samadi-Shams; Sina Atashpaz; Sajjad Khani
Journal:  Bioimpacts       Date:  2011-09-30

9.  Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines.

Authors:  Yuan Lu; John P Welsh; James R Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-16       Impact factor: 11.205

Review 10.  Small-Molecule Inhibition of Viral Fusion Glycoproteins.

Authors:  Han-Yuan Liu; Priscilla L Yang
Journal:  Annu Rev Virol       Date:  2021-07-01       Impact factor: 10.431
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.